Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer
- Neil A. Goldman, an experienced executive in the industry, joins LSO as its new CFO. He has a track record of building teams, scaling operations, and driving business growth. His appointment is expected to contribute to LSO's continued success and growth.
- None.
Mr. Goldman joins LSO from BioPorto A/S (CPH:BIOPOR), a global developer and manufacturer of kidney diagnostics and a portfolio of antibodies. At BioPorto, where Mr. Goldman served as Executive Vice President and CFO, he raised over DKK 140 million to fund the Company through timely completion of its clinical trials and review by the US Food and Drug Administration.
CEO John Nino commented on the appointment, stating, "We are excited to welcome Neil to our executive team. With his impressive track record in the industry and breadth of experience building teams, scaling operations, and driving business through organic growth and strategic relationships, we are confident he will be instrumental in LSO's continued success and growth."
Previously, Mr. Goldman was an executive at Chembio Diagnostics, Inc. (formerly NASDAQ:CEMI), J.S. Held LLC, and Unwired Technology LLC. As Executive Vice President and CFO of Chembio, he drove transformative milestones, including a significant revenue boost, an expanded institutional shareholder base, and two foreign acquisitions. At J.S. Held, where he served as Executive Vice President-Corporate Development and CFO, he helped lead substantial sales and EBITDA growth, including closing a series of acquisitions. At Unwired, a hi-tech, tier-1 automotive electronics manufacturer, he held positions including Executive Vice President-Corporate Development and CFO, and Senior Vice President-Chief Operating & Financial Officer. He joined Delphi Corp., now Aptiv plc (NYSE:APTV), following Delphi's acquisition of Unwired, which delivered a significant return on investment for shareholders.
Mr. Goldman began his career at Ernst & Young, where he was an auditor of Fortune 500 manufacturers and advanced into regional and national management consulting positions.
He holds a B.S. in Business-Accountancy from
John Nino further stated, "With Neil onboard, LSO is poised to fortify its position as a premier Contract Manufacturing Organization. We look forward to the new horizons and possibilities his leadership and expertise will unlock for our company."
About Life Science Outsourcing
Life Science Outsourcing is an FDA-registered and ISO 13485-certified Contract Manufacturing Organization with over 125,000 sq ft of bicoastal production operations with cleanroom capabilities, including locations in
View original content to download multimedia:https://www.prnewswire.com/news-releases/life-science-outsourcing-inc-welcomes-neil-a-goldman-as-chief-financial-officer-301958348.html
SOURCE Life Science Outsourcing, Inc.
FAQ
Who is the new CFO of Life Science Outsourcing, Inc. (LSO)?
What is the background of Neil A. Goldman?
What is the significance of Neil A. Goldman's appointment for LSO?